These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2149311)

  • 1. [Clinical-instrumental evaluation of the effects of quinapril treatment in mild-to-moderate hypertension].
    Saitta A; Bonaiuto M; Mileto A; Oriti S; Campo S; Giordano G; Cinquegrani M; Saitta MN; Fodale P
    Clin Ter; 1990 Sep; 134(5):289-99. PubMed ID: 2149311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Study Group of Quinapril in Arterial Hypertension. The Steering Committee].
    Ambrosioni E; Brusca A; Caponnetto S; Condorelli M; Corea L; Dal Palù C; Fogari R; Mameli P; Mancia G; Neri Serneri GG
    Minerva Cardioangiol; 1992 Mar; 40(3):85-96. PubMed ID: 1630680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative study of the efficacy of lisinopril versus quinapril in controlling light to moderate arterial hypertension. A follow-up with ABPM].
    Motero Carrasco J
    Rev Esp Cardiol; 1995 Nov; 48(11):746-53. PubMed ID: 8532944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinapril versus enalapril in the treatment of mild-to-moderate essential hypertension.
    Sánchez S; Luna A; Orozco R; Velasco G
    Clin Ther; 1991; 13(5):651-5. PubMed ID: 1799922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
    Ding YA; Chang SM; Chou TC
    J Hum Hypertens; 1995 Aug; 9(8):637-41. PubMed ID: 8523379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of quinapril hydrochloride in patients with essential hypertension and impaired renal function.
    Owada A; Nonoguchi H; Terada Y; Marumo F; Tomita K
    Clin Exp Hypertens; 1997 May; 19(4):495-502. PubMed ID: 9140710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
    Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of quinapril on the albumin excretion rate in patients with mild to moderate essential hypertension. Multicenter Study Group.
    Larochelle P
    Am J Hypertens; 1996 Jun; 9(6):551-9. PubMed ID: 8783779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response to the first dose of an angiotensin converting enzyme inhibitor in uncomplicated hypertension--a placebo controlled study utilising ambulatory blood pressure recording.
    MacFadyen RJ; Bainbridge AD; Lees KR; Reid JL
    Br J Clin Pharmacol; 1991 Sep; 32(3):393-8. PubMed ID: 1777377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of quinapril versus atenolol: effects on blood pressure and cardiac mass after renal transplantation.
    Suwelack B; Gerhardt U; Hausberg M; Rahn KH; Hohage H
    Am J Cardiol; 2000 Sep; 86(5):583-5, A10. PubMed ID: 11009288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension.
    Bahena JH; Estrella ME; Muñoz M
    Clin Ther; 1992; 14(4):527-36. PubMed ID: 1525787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
    Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of cardiovascular risk factors during antihypertensive treatment: a multicentre trial with quinapril.
    Manzato E; Capurso A; Crepaldi G
    J Int Med Res; 1993; 21(1):15-25. PubMed ID: 8319817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the clinical development of quinapril.
    Frank GJ
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can an angiotensin-converting enzyme inhibitor with a short half-life effectively lower blood pressure for 24 hours?
    Palatini P
    Am Heart J; 1992 May; 123(5):1421-5. PubMed ID: 1575169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacodynamic responses of hypertensive patients to quinapril therapy.
    Fernandez PG; Snedden W
    Can J Cardiol; 1992 Mar; 8(2):189-94. PubMed ID: 1559192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A postmarketing surveillance evaluation of quinapril in 3742 Canadian hypertensive patients: the ACCEPT Study. Accupril Canadian Clinical Evaluation and Patient Teaching.
    Larochelle P; Haynes B; Maron N; Dugas S
    Clin Ther; 1994; 16(5):838-53. PubMed ID: 7859244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension.
    Vallès Prats M; Matas Serra M; Bronsoms Artero J; Matè Benito G; Torguet Escuder P; Mauri Nicolas JM
    Kidney Int Suppl; 1996 Jun; 55():S104-6. PubMed ID: 8743525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of quinapril and triamterene/hydrochlorothiazide on cardiac and vascular end-organ damage in isolated systolic hypertension.
    Heesen WF; Beltman FW; Smit AJ; May JF; de Graeff PA; Havinga TK; Schuurman FH; van der Veur E; Meyboom-de Jong B; Lie KI
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):187-94. PubMed ID: 9475259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.